We invested in DarioHealth because chronic disease management remains one of the largest and most important challenges in healthcare. We are interested in businesses that can improve outcomes through personalized, data-informed support while also aligning with the growing demand for scalable models of ongoing care. DarioHealth reflects that thesis through a digital therapeutics approach aimed at helping patients manage long-term conditions more effectively. The company also fits our broader interest in solutions that combine technology, engagement, and measurable health relevance. In chronic care, lasting value often comes from helping patients sustain behavior change and stay connected to useful interventions over time. We believe that is an important and durable part of the healthcare landscape.